The Chronic Effects of Carnitine on Recovery
CompletedNot applicableNCT04420377
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study investigated the effects of CarnipureTM, a high-quality L-carnitine ingredient, on long term (5 weeks) recovery, muscle damage, and SOD status in a population of males and females while training two days per week. The primary outcomes defining recovery were changes in serum creatine kinase levels and perceptual changes in recovery. Supporting variables included an assessment of strength and power as a functional indicator of recovery. This study would be the first to examine the effects of CarnipureTM on long-term recovery. Our primary hypothesis was that L-carnitine supplementation would reduce muscle damage and improve perceptual measures of recovery. Our secondary hypotheses were that L-carnitine supplementation would better sustain strength and power and elevate SOD status.
Study details
- Official title
- The Chronic Effects of L-Carnitine Tartrate Supplementation on Recovery
- Conditions
- Muscle Soreness
- Muscle Damage
- Resistance Training
- Oxidative Stress
- Muscle Strength
- Interventions
- Dietary supplement: Carnipure
- Other: Resistance Training
- Sponsor
- Applied Science & Performance Institute
- Collaborators
- Lonza Ltd.
- Start date
- 2020-03-02
- Primary completion
- 2020-06-12
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: \- Participation in at least 30 minutes of moderate activity exercise 3 times per week Exclusion Criteria: * Body-mass index (BMI) of ≥ 30 kg/m²; * Cardiovascular, metabolic, endocrine, or thyroid disease * Smoking tobacco * Drinking alcohol (\>7 or \>14 drinks per week for women and men, respectively) * Pregnancy * Hypertension * Hyperlipidemia * Hyperglycemia * Thyroid disease * Metabolic disease * Type I or Type II Diabetes * Use of anabolic-androgenic steroids * Use of antioxidant supplements, NSAIDS, or nutritional supplements known to stimulate recovery or muscle mass gains, heart disease, prescription medications, dietary supplements that enhance muscle strength or muscle recovery
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04420377